Cita APA (7a ed.)
Palacios, S., Bonnick, S., De Villiers, T., Chapurlat, R., Odio, A., Scott, B., . . . Gurner, D. (Jun 2013). OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- a Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2013-eular.452
Cita Chicago Style (17a ed.)
Palacios, S., et al. "OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- a Randomized Placebo-Controlled Trial." Annals of the Rheumatic Diseases Jun 2013. https://doi.org/10.1136/annrheumdis-2013-eular.452.
Cita MLA (9a ed.)
Palacios, S., et al. "OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- a Randomized Placebo-Controlled Trial." Annals of the Rheumatic Diseases, Jun 2013, https://doi.org/10.1136/annrheumdis-2013-eular.452.
Precaución: Estas citas no son 100% exactas.